Biote Corp. Q1 2025 10-Q: Earnouts & Equity Plans

Ticker: BTMD · Form: 10-Q · Filed: May 9, 2025 · CIK: 1819253

Sentiment: neutral

Topics: 10-Q, financials, earnouts, equity-plans

TL;DR

Biote's Q1 10-Q shows earnout liabilities and details on equity plans.

AI Summary

Biote Corp. filed its 10-Q for the period ending March 31, 2025, reporting on its financial performance. The filing details various financial instruments and agreements, including an Earnout Liability and a Truist Term Loan. It also mentions equity awards under the Two Thousand Twenty-Two Equity Incentive Plan and the Two Thousand Twenty-Two Employee Stock Purchase Plan.

Why It Matters

This filing provides insight into Biote Corp.'s financial structure and ongoing commitments, which can affect its future financial health and stock valuation.

Risk Assessment

Risk Level: medium — The filing mentions earnout liabilities and subsequent events, which can introduce financial uncertainty.

Key Players & Entities

FAQ

What is the status of Biote Corp.'s Earnout Liability as of March 31, 2025?

The filing indicates a 'Level3EarnoutLiabilityMember' as of March 31, 2025, related to Simpatra LLC.

Does Biote Corp. have any outstanding revolving credit facilities?

Yes, the filing mentions a 'TruistTermLoanMember' which is a 'RevolvingCreditFacilityMember' for the period of January 1, 2025, to March 31, 2025.

What significant events occurred after the reporting period?

A subsequent event on April 23, 2025, involved 'ClassACommonUnitsAndClassVVotingStockMember'.

Are there any details on Biote Corp.'s equity incentive plans?

The filing references the 'TwoThousandTwentyTwoEquityIncentivePlanMember' for Restricted Stock Units (RSUs) during the period of January 1, 2025, to March 31, 2025.

What was Biote Corp.'s former company name?

Biote Corp. was formerly known as Haymaker Acquisition Corp. III, with a name change date of July 27, 2020.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 9, 2025 regarding biote Corp. (BTMD).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing